These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25182066)

  • 1. Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
    Cojutti P; Maximova N; Crichiutti G; Isola M; Pea F
    J Antimicrob Chemother; 2015 Jan; 70(1):198-206. PubMed ID: 25182066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
    Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
    Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
    Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M
    J Antimicrob Chemother; 2012 Aug; 67(8):2034-42. PubMed ID: 22553142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients.
    Pea F; Viale P; Lugano M; Baccarani U; Pavan F; Tavio M; Adani GL; Della Rocca G; Furlanut M
    J Antimicrob Chemother; 2009 Jan; 63(1):167-9. PubMed ID: 18952619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
    Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
    Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
    MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii17-25. PubMed ID: 12730139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
    Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
    J Infect Chemother; 2015 Jan; 21(1):70-3. PubMed ID: 25305808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.
    Dong H; Xie J; Wang T; Chen L; Zeng X; Sun J; Wang X; Dong Y
    Int J Antimicrob Agents; 2016 Sep; 48(3):259-64. PubMed ID: 27474469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
    Cojutti P; Pai MP; Pea F
    Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.
    Pea F; Furlanut M; Cojutti P; Cristini F; Zamparini E; Franceschi L; Viale P
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4605-10. PubMed ID: 20733043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic research on three different infusion time regimens of linezolid in healthy Chinese volunteers.
    Cai Y; Bai N; Liu X; Liang B; Wang J; Wang R
    Int J Clin Pharmacol Ther; 2015 Sep; 53(9):765-71. PubMed ID: 26227096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.
    Rayner CR; Forrest A; Meagher AK; Birmingham MC; Schentag JJ
    Clin Pharmacokinet; 2003; 42(15):1411-23. PubMed ID: 14674791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
    Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
    Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
    Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.
    Pea F; Poz D; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2006 Aug; 58(2):380-6. PubMed ID: 16735422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
    Batts DH; Lavin BS; Eliopoulos GM
    Curr Clin Top Infect Dis; 2001; 21():227-51. PubMed ID: 11572153
    [No Abstract]   [Full Text] [Related]  

  • 17. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases.
    Garazzino S; Krzysztofiak A; Esposito S; Castagnola E; Plebani A; Galli L; Cellini M; Lipreri R; Scolfaro C; Bertaina C; Calitri C; Bozzola E; Lancella L; Quondamcarlo A; Bosis S; Pugni L; Losurdo G; Soresina A; De Gaudio M; Mariotti I; Mancini L; Gabiano C; Tovo PA
    J Antimicrob Chemother; 2011 Oct; 66(10):2393-7. PubMed ID: 21764828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid: in infants and children with severe Gram-positive infections.
    Lyseng-Williamson KA; Goa KL
    Paediatr Drugs; 2003; 5(6):419-29; discussion 430-1. PubMed ID: 12765493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the use of linezolid: a pediatric perspective.
    Tan TQ
    Pediatr Infect Dis J; 2004 Oct; 23(10):955-6. PubMed ID: 15602197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.